Detalhe da pesquisa
1.
Adding Umbralisib and Ublituximab (U2) to Ibrutinib in Patients with CLL: A Phase II Study of an MRD-Driven Approach.
Clin Cancer Res
; 28(18): 3958-3964, 2022 09 15.
Artigo
Inglês
| MEDLINE | ID: mdl-35852793
2.
Hypersensitivity Reactions: Priming Practice Change to Reduce Incidence in First-Dose Rituximab Treatment.
Clin J Oncol Nurs
; 22(4): 407-414, 2018 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30035788
3.
COVID-19 vaccine efficacy in patients with chronic lymphocytic leukemia.
Leukemia
; 35(9): 2703-2705, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-33986431
4.
Why did you switch from full-time to part-time?
ONS Connect
; 26(3): 13, 2011 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-21473529